What's new

Orphan designation: paltusotine Treatment of acromegaly, 26/02/2025 Positive

Orphan designation: paltusotine Treatment of acromegaly, 26/02/2025 Positive

Mar 11, 2025 - 11:59
 0
Orphan designation: paltusotine Treatment of acromegaly, 26/02/2025 Positive
Orphan designation: paltusotine Treatment of acromegaly, 26/02/2025 Positive
Read More

Tags:

Previous Article

Anantara Sir Bani Yas Island upgrades Al Sahel resort villas

Next Article

The Mexican women who defied drug-dealers, fly-tippers and chauvinists to build ...

Related Posts

Human medicines European public assessment report (EPAR): Pedea, ibuprofen, Date of authorisation: 28/07/2004, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 10, 2025  0

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0